Viral in Medical Technology
Navigation Links
Viral in Medical Technology
... and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the ... which act as alternative substrates for the viral polymerase thus inhibiting viral replication. We currently have three ...
... The disorder is often related to a viral infection. The nerve that controls facial muscles ... becomes inflamed or swollen, typically due to a viral infection, it can become compressed, irritated ... most likely to occur in people who have certain viral infections, such as cold sores or upper ...
... development of drugs for the treatment of human viral diseases, today announced that it has ... between IDX184- and placebo-treated patients. viral load declines were observed in 30 of the 31 ... in one patient in the 25 mg cohort. Significant viral load reductions were observed in the three higher ...
... 48 weeks of treatment, with response defined as a viral load of <50 copies/mL measured at two ... percent achieved the study's primary endpoint of viral load of <50 copies/mL versus 65 percent of ... 48.(1) In patients who began study treatment with viral loads above 100,000 copies/mL, 60 percent of ...
... study to assess the role of the ImmuKnow assay in viral surveillance and immune function monitoring in 35 ... immunosuppressive therapy." For each patient, viral studies and ImmuKnow results were routinely ... drug dosing was adjusted based on positive viral studies using ImmuKnow results as an adjunct ....
... have been recommended as a standard protocol for viral load testing in HIV/AIDS clinical trials ... in 2009 and beyond that have a primary focus on viral load measurements. The recommendation applies to ... network laboratories in the United States. viral load testing is a monitoring tool used to ...
... for developing test kits for the detection of viral hemorrhagic fever (VHF). The National ... proteins for Lassa virus and developed several viral detection products which were deployed in Africa ... MPH, Director, Global Field Operations, Global viral Forecasting Initiative, San Francisco, a ...
... (HCV RNA) with at least a 2 log10 reduction in viral load at treatment week 12 and undetectable virus ... to treatment (less than a 2 log10 reduction in viral load at week 12) were discontinued from the ... were G3 and 53.1 percent had high baseline viral load (greater than or equal to 600,000 IU/mL), ...
... inhibitor, shows significant potency in reducing viral load in patients with hepatitis C - NUTLEY, ... polymerase inhibitor resulted in significant HCV viral load reduction in patients with HCV. Roche is ... or ribavirin -- experienced a median reduction in viral levels of -4.8 to -5.2 log(10) IU/mL in the ...
... and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the ... have compensated liver disease and evidence of viral replication and liver inflammation). PEGASYS ... multiforme major, and infections (bacterial, viral and fungal). About Roche Hoffmann-La ...
... the ITMN-191 900 mg q12h dosing cohort. viral rebound was not observed in any patient receiving ... of the study, said, "Based on the totality of the viral kinetic data, the q12h and q8h regimens delivered ... 24-week treatment durations. We believe that the viral kinetic and safety results reported today provide ...
... levels. At 200 mg bid (twice-daily), the median viral load reduction was 2.4 log10 (range of 0.4 to ... the 12 genotype 1a patients who received ANA598, viral load was still declining at the end of the three ... bid, respectively. No patient showed evidence of viral rebound while on ANA598. ANA598 was ...
... in the lead-in arms discontinued treatment due to viral breakthrough. "These results are very ... REBETOL regimen was associated with increased viral breakthrough during treatment, higher relapse ... discontinuations for boceprevir patients due to viral breakthrough were fewer in the 28- and 48-week ...
... the XI International Symposium on Respiratory viral Infections taking place in Bangkok, Thailand, ... objectives of the study included evaluation of viral shedding, mortality, clinical relapse and time to ... endpoint was driven by resolution of fever. viral shedding (time weighted change from baseline ...
... needed to address the increasing prevalence of viral resistance and side effects associated with this ... oral administration of IDX899 achieved mean viral load reductions of 1.8 log(10), after seven days ... development of drugs for the treatment of human viral and other infectious diseases. Idenix's current ...
... development of drugs for the treatment of human viral and other infectious diseases, today announced ... of 10 mg/kg/day of IDX184 produced a mean viral load reduction of 2.3 log10 after four days of ... development of drugs for the treatment of human viral and other infectious diseases. Idenix's current ...
... 90 percent of patients achieve undetectable viral load in Phase IIa trial within 28 days of ... In the 75 mg four-week triple therapy arm, no viral breakthrough was observed; 9/9 patients achieved ... C recurrence after liver transplantation. J viral Hepat. 2007 Nov;14 Suppl 1:89-96. Roche B, ...
... Inhibitor ANA598 have the Potential to Overcome viral Resistance", Anadys will present the results ... genotype 1b animals dosed over four days, maximum viral load reductions of 2.2 and 2.6 log10 were ... hours after the initial dose. In one animal the viral load reduction was sustained throughout the ...
... CCR5 receptor antagonist, demonstrated sustained viral suppression and increased CD4 cell counts and was ... background therapy may provide durable viral suppression and sustained elevated CD4 counts in ... long-term. Median change from baseline viral load (HIV RNA) was -2.1, -2.2, -2.3, -2.3 (log10) ...
... ritonavir (r) once daily reached an undetectable viral load (<50 copies/mL) at week 96, compared with 71 ... the PREZISTA/r arm reached an undetectable viral load ( lopinavir/r arm, (p=0.012). -- Of patients with baseline viral load greater than and equal to 100,000 ...
... and two on placebo. Anadys expects to have viral load data from all three cohorts in the first ... Inhibitor ANA598 have the Potential to Overcome viral Resistance", Anadys will present the results ... infection, leading to a greater than 2 log viral load decline in each of two genotype 1b infected ...
... that the 100 mg/day cohort achieved a mean plasma viral load reduction of 1.87 log10 after seven days of ... receiving IDX899 in this trial achieved potent viral suppression at all doses tested," said ... 400 mg, 200 mg and 100 mg of IDX899 achieved mean viral load reductions of 1.78, 1.78, 1.84 and 1.87 ...
... and females who achieved an undetectable HIV viral load were similar. In addition, the proportions ... and non-whites who achieved an undetectable HIV viral load were similar. Specifically, 72 percent of ... of the twice-daily treated patients achieved a viral load <50 copies/mL. The once-daily regimen ...
... resulted in significant reductions in plasma viral load that were consistent with results previously ... end point was the change from baseline in plasma viral load. Top-line results from all four cohorts ... following: -- The median reduction in plasma viral load at nadir was 1.9 - 2.1 log copies/ml ...
... once-daily IDX899 achieved a mean plasma viral load reduction of approximately 1.8 log(10) after ... receiving placebo had a 0.05 log10 viral load increase over the same treatment period. No ... showing that IDX899 offers potent viral suppression combined with a promising safety ...
... this study, in the 28-week treatment arm, rapid viral response (RVR) criteria at 4 weeks of boceprevir ... HCV genotype 1 subtype 1a versus 1b, and baseline viral load. Professor Jean-Pierre Bronowicki, M.D., ... by achieving at least a 2 log decrease in viral load by week 12 of peginterferon and ribavirin ...
... (primary endpoint). Suppression of viral load to undetectable levels is a measure of ... E.A.R.L.Y. study is an open-label, randomized, viral kinetics study of 69 antiviral-naive chronic ... adefovir. All patients in this study had a high viral load at study entry.(1) Of the 49 patients who ...
... development of drugs for the treatment of human viral and other infectious diseases, today announced ... of 10 mg/kg of IDX184 resulted in a mean viral load reduction of 2.3 log10 (n=5) after four days ... of drugs for the treatment of human viral and other infectious diseases. Idenix's current ...
... Saturday, April 26, 4:45 p.m. Hall A. Sustained viral response (SVR) is dependent on baseline ... et al. Platelet count predicts sustained viral response (SVR) in the retreatment of previous ... EPIC3 program. Poynard, T. et. al. Impact of viral load and cirrhosis on treatment outcome in HCV ...
... with the goal of reducing or eliminating periodic viral flare-ups and the associated viral shedding and transmission. "HSV-2 infection is ... sufficient to reduce or eliminate periodic viral flare-ups and the associated viral shedding and ...
... treatment gap of less than or equal to 35 days. viral load reduction in chronic hepatitis B patients ... able to achieve and maintain an undetectable viral load (HBV DNA <300 copies/mL) through year ... patients achieved undetectable viral load ( breakthrough due to BARACLUDE ...
... tested so far produce robust reductions in plasma viral load and are well tolerated. "These preliminary ... endpoint is the change from baseline in plasma viral load. Preliminary results, which include those ... log placebo-adjusted mean reduction in plasma viral load. -- Patients receiving 600 mg once daily ...
... The disorder is often related to a viral infection. The nerve that controls facial muscles ... becomes inflamed or swollen, typically due to a viral infection, it can become compressed, irritated ... most likely to occur in people who have certain viral infections, such as cold sores or upper ...
... development of drugs for the treatment of human viral diseases, today announced that it has ... between IDX184- and placebo-treated patients. viral load declines were observed in 30 of the 31 ... in one patient in the 25 mg cohort. Significant viral load reductions were observed in the three higher ...
... 48 weeks of treatment, with response defined as a viral load of <50 copies/mL measured at two ... percent achieved the study's primary endpoint of viral load of <50 copies/mL versus 65 percent of ... 48.(1) In patients who began study treatment with viral loads above 100,000 copies/mL, 60 percent of ...
Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis
... patented lead Aganocide(R) compound, NVC-422, for viral conjunctivitis, a type of "pink eye". ... to traditional antibiotics. The Phase 2 viral conjunctivitis study follows a recently completed ... to be entering mid-stage clinical testing for viral conjunctivitis," said Ron Najafi, Ph.D., chairman ...... study to assess the role of the ImmuKnow assay in viral surveillance and immune function monitoring in 35 ... immunosuppressive therapy." For each patient, viral studies and ImmuKnow results were routinely ... drug dosing was adjusted based on positive viral studies using ImmuKnow results as an adjunct ....
... have been recommended as a standard protocol for viral load testing in HIV/AIDS clinical trials ... in 2009 and beyond that have a primary focus on viral load measurements. The recommendation applies to ... network laboratories in the United States. viral load testing is a monitoring tool used to ...
... for developing test kits for the detection of viral hemorrhagic fever (VHF). The National ... proteins for Lassa virus and developed several viral detection products which were deployed in Africa ... MPH, Director, Global Field Operations, Global viral Forecasting Initiative, San Francisco, a ...
New Study Shows Probiotic Strain Effective in Boosting Immune Response to Flu Virus
... showed a 1709% increase in TNF-alpha levels upon viral challenge after subjects took Sustenex for a ... increased production of TNF-alpha in response to viral exposure indicates a heightened immunological ... Bacillus coagulans Increased Immune Response to viral Challenge, published in Postgraduate Medicine , ...... (HCV RNA) with at least a 2 log10 reduction in viral load at treatment week 12 and undetectable virus ... to treatment (less than a 2 log10 reduction in viral load at week 12) were discontinued from the ... were G3 and 53.1 percent had high baseline viral load (greater than or equal to 600,000 IU/mL), ...
... inhibitor, shows significant potency in reducing viral load in patients with hepatitis C - NUTLEY, ... polymerase inhibitor resulted in significant HCV viral load reduction in patients with HCV. Roche is ... or ribavirin -- experienced a median reduction in viral levels of -4.8 to -5.2 log(10) IU/mL in the ...
... and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the ... have compensated liver disease and evidence of viral replication and liver inflammation). PEGASYS ... multiforme major, and infections (bacterial, viral and fungal). About Roche Hoffmann-La ...
... the ITMN-191 900 mg q12h dosing cohort. viral rebound was not observed in any patient receiving ... of the study, said, "Based on the totality of the viral kinetic data, the q12h and q8h regimens delivered ... 24-week treatment durations. We believe that the viral kinetic and safety results reported today provide ...
... levels. At 200 mg bid (twice-daily), the median viral load reduction was 2.4 log10 (range of 0.4 to ... the 12 genotype 1a patients who received ANA598, viral load was still declining at the end of the three ... bid, respectively. No patient showed evidence of viral rebound while on ANA598. ANA598 was ...
... in the lead-in arms discontinued treatment due to viral breakthrough. "These results are very ... REBETOL regimen was associated with increased viral breakthrough during treatment, higher relapse ... discontinuations for boceprevir patients due to viral breakthrough were fewer in the 28- and 48-week ...
SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production
... of EX-CELL(TM) EBx (R) cell growth and viral production media designed exclusively to support ... enable EB66 licensees in the development of viral vaccine therapeutics. In addition, Vivalis plans ... for the safe, cost effective manufacturing of viral vaccines and recombinant proteins for human and ...... the XI International Symposium on Respiratory viral Infections taking place in Bangkok, Thailand, ... objectives of the study included evaluation of viral shedding, mortality, clinical relapse and time to ... endpoint was driven by resolution of fever. viral shedding (time weighted change from baseline ...
... needed to address the increasing prevalence of viral resistance and side effects associated with this ... oral administration of IDX899 achieved mean viral load reductions of 1.8 log(10), after seven days ... development of drugs for the treatment of human viral and other infectious diseases. Idenix's current ...
... development of drugs for the treatment of human viral and other infectious diseases, today announced ... of 10 mg/kg/day of IDX184 produced a mean viral load reduction of 2.3 log10 after four days of ... development of drugs for the treatment of human viral and other infectious diseases. Idenix's current ...
ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
... Phase Ib trial demonstrated a 2.5 log10 median viral load decline after three days Conference ... At the end of the treatment period, the median viral load decline was 2.5 log10 (>99%), with a ... ANA598 were genotype 1a and demonstrated a median viral load decline of 1.6 log10, while five patients ...... 90 percent of patients achieve undetectable viral load in Phase IIa trial within 28 days of ... In the 75 mg four-week triple therapy arm, no viral breakthrough was observed; 9/9 patients achieved ... C recurrence after liver transplantation. J viral Hepat. 2007 Nov;14 Suppl 1:89-96. Roche B, ...
... Inhibitor ANA598 have the Potential to Overcome viral Resistance", Anadys will present the results ... genotype 1b animals dosed over four days, maximum viral load reductions of 2.2 and 2.6 log10 were ... hours after the initial dose. In one animal the viral load reduction was sustained throughout the ...
... CCR5 receptor antagonist, demonstrated sustained viral suppression and increased CD4 cell counts and was ... background therapy may provide durable viral suppression and sustained elevated CD4 counts in ... long-term. Median change from baseline viral load (HIV RNA) was -2.1, -2.2, -2.3, -2.3 (log10) ...
... ritonavir (r) once daily reached an undetectable viral load (<50 copies/mL) at week 96, compared with 71 ... the PREZISTA/r arm reached an undetectable viral load ( lopinavir/r arm, (p=0.012). -- Of patients with baseline viral load greater than and equal to 100,000 ...
... and two on placebo. Anadys expects to have viral load data from all three cohorts in the first ... Inhibitor ANA598 have the Potential to Overcome viral Resistance", Anadys will present the results ... infection, leading to a greater than 2 log viral load decline in each of two genotype 1b infected ...
FDA Approves First Hepatitis B Viral Load Test
... B virus DNA in a patient's blood. Doctors may use viral load testing results to establish a baseline ... to bring that same level of standardized viral load measurement to Hepatitis B treatment." ... in the patient's blood, it is critical for viral load monitoring tests to be able to quantify very ...... that the 100 mg/day cohort achieved a mean plasma viral load reduction of 1.87 log10 after seven days of ... receiving IDX899 in this trial achieved potent viral suppression at all doses tested," said ... 400 mg, 200 mg and 100 mg of IDX899 achieved mean viral load reductions of 1.78, 1.78, 1.84 and 1.87 ...
Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program
... a statistically significant reduction of viral load in the blood of chronically infected ... end of IC41 vaccination revealed an even greater viral load decline of 0.46 log (p=0.001). ... was most pronounced in patients with high initial viral load (> 2 million copies/ml). A parallel study ...... and females who achieved an undetectable HIV viral load were similar. In addition, the proportions ... and non-whites who achieved an undetectable HIV viral load were similar. Specifically, 72 percent of ... of the twice-daily treated patients achieved a viral load <50 copies/mL. The once-daily regimen ...
... resulted in significant reductions in plasma viral load that were consistent with results previously ... end point was the change from baseline in plasma viral load. Top-line results from all four cohorts ... following: -- The median reduction in plasma viral load at nadir was 1.9 - 2.1 log copies/ml ...
... once-daily IDX899 achieved a mean plasma viral load reduction of approximately 1.8 log(10) after ... receiving placebo had a 0.05 log10 viral load increase over the same treatment period. No ... showing that IDX899 offers potent viral suppression combined with a promising safety ...
... this study, in the 28-week treatment arm, rapid viral response (RVR) criteria at 4 weeks of boceprevir ... HCV genotype 1 subtype 1a versus 1b, and baseline viral load. Professor Jean-Pierre Bronowicki, M.D., ... by achieving at least a 2 log decrease in viral load by week 12 of peginterferon and ribavirin ...
... (primary endpoint). Suppression of viral load to undetectable levels is a measure of ... E.A.R.L.Y. study is an open-label, randomized, viral kinetics study of 69 antiviral-naive chronic ... adefovir. All patients in this study had a high viral load at study entry.(1) Of the 49 patients who ...
... development of drugs for the treatment of human viral and other infectious diseases, today announced ... of 10 mg/kg of IDX184 resulted in a mean viral load reduction of 2.3 log10 (n=5) after four days ... of drugs for the treatment of human viral and other infectious diseases. Idenix's current ...
Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
... SVR in a limited subset of patients with low viral load. In this randomized, controlled study, ... tablet twice daily for 24 weeks. Baseline viral loads and other disease characteristics were ... HCV RNA did not show significant reductions in viral load or alanine aminotransferase (ALT) ....... Saturday, April 26, 4:45 p.m. Hall A. Sustained viral response (SVR) is dependent on baseline ... et al. Platelet count predicts sustained viral response (SVR) in the retreatment of previous ... EPIC3 program. Poynard, T. et. al. Impact of viral load and cirrhosis on treatment outcome in HCV ...
Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
... demonstrated potent and sustained viral suppression through 48 weeks of treatment.(4, 5) ... of the study is the mean change from baseline in viral load (log10 HIV RNA) at week 48 of treatment. A ... exhibits potent, sustained suppression of viral replication in treatment-experienced adults: ...... with the goal of reducing or eliminating periodic viral flare-ups and the associated viral shedding and transmission. "HSV-2 infection is ... sufficient to reduce or eliminate periodic viral flare-ups and the associated viral shedding and ...
... treatment gap of less than or equal to 35 days. viral load reduction in chronic hepatitis B patients ... able to achieve and maintain an undetectable viral load (HBV DNA <300 copies/mL) through year ... patients achieved undetectable viral load ( breakthrough due to BARACLUDE ...
... tested so far produce robust reductions in plasma viral load and are well tolerated. "These preliminary ... endpoint is the change from baseline in plasma viral load. Preliminary results, which include those ... log placebo-adjusted mean reduction in plasma viral load. -- Patients receiving 600 mg once daily ...
Other ContentssprainssprainssprainssquamoussquamoussquamoussquamoussquamoussputumsputumspurspurspurspursquintsteinaureusaureusaureusaureusaureusaureusstaphylococcusstaphylococcusOther TagseMedeMedupsupsupsupsupslurelurelurelureWaitCTOCTOCTOCTOCTOCTOCTOCTOOther Tagsdelays 2delays 3delays 4delays 5delays 6delays 7approval 2approval 3approval 4approval 5approval 6approval 7approval 8approval 9approval 10destroys 2destroys 3destroys 4destroys 5destroys 6destroys 7kill 2kill 3kill 4kill 5kill 6kill 7kill 8kill 9kill 10derivatives 2seeds 2seeds 3rainfall 2
(Date:11/9/2009)...ed in California and elsewhere provide support for... fisheries and protecting marine habitats, accordi...Santa Cruz. , A recent study in the Gulf of Cal...key concept behind marine reserves--the idea that ...sh the stocks of harvested species outside the res...
(Date:11/9/2009)...partment of Energy (DOE) has announced plans to fu...gham (UAB) School of Engineering on technologies t...ough the capture and permanent safe storage, or se...is in collaboration with Southern Company, the par...E through the 2009 American Recovery and Reinvestm...
(Date:11/9/2009)...PRNewswire/ -- Genencor, a division of Danisco, ha... the American Institute of Chemical Engineers (AIC...r cellulosic ethanol. Yesterday, Robert Davis, Cha...ard to Landon Steele, who is Marketing Director, B...er, and Aaron Kelley, who is Senior Engineer, Biom...
Breaking Biology News(10 mins):Studies show marine reserves can be an effective tool for managing fisheries 2Studies show marine reserves can be an effective tool for managing fisheries 3Studies show marine reserves can be an effective tool for managing fisheries 4Studies show marine reserves can be an effective tool for managing fisheries 5UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2AstraZeneca Among Working Mother Magazines 2009 Best Companies 58005 1AstraZeneca Among Working Mother Magazines 2009 Best Companies 58005 2AstraZeneca Among Working Mother Magazines 2009 Best Companies 58005 3Caring Candles Embrace Caregivers and Help Spread the Light 58003 1Caring Candles Embrace Caregivers and Help Spread the Light 58003 2Hard To Treat Diseases 28HTDS 29 Delivers Varicella Vaccine To Guatemala 58001 1Hard To Treat Diseases 28HTDS 29 Delivers Varicella Vaccine To Guatemala 58001 2Hard To Treat Diseases 28HTDS 29 Delivers Varicella Vaccine To Guatemala 58001 3[0] Studies show marine reserves can be an effective tool for managing fisheries[0] UAB, partners seek safe carbon dioxide storage for 'greener' power generation[0] Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes
(Date:11/9/2009)..., Ill., Nov. 9 The House version o... for America Act , which passed by a vote of 220-2...l significant changes to the tax code and differs ...ear in any Senate version, requiring extensive rec...ed a Special Tax Briefing on the tax provision...
(Date:11/9/2009)...sion, Antitrust Language, Federal Trade Commission... WASHINGTON, Nov. 9 Inc...e for America Act (H.R. 3962) allowing insurance a...surance exchanges is positive, but other issues re...he National Association of Professional Insurance ...
(Date:11/9/2009)...ion backs President Obama,s promise to not expand ... ,, Bishops still concerned for poor, elderly ...-- Cardinal Francis George of Chicago, president o..., lauded the November 7 decision of the U.S. House...eform money from paying for elective abortions. ,...
(Date:11/9/2009)...ports success with drugs that inhibit estrogen, ,...o drugs used to treat breast cancer and osteoporos...o a new study. , The drugs also cleared precanc...ted the onset of cancer in mice with precancerous ...nd the breast cancer/osteoporosis drug raloxifene ...
(Date:11/9/2009)...n and women almost equally, study finds, , ...y used clot-dissolving drug Plavix (clopidogrel) w...s of major clinical trials has found. , "After ...ing both men and women with this very important dr...ovascular thrombosis at New York University Langon...
Breaking Medicine News(10 mins):Health News:CCH Briefing Details Tax Provisions of House Health Care Bill 2Health News:PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain 2Health News:PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain 3Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3[0] CCH Briefing Details Tax Provisions of House Health Care Bill[0] PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain[0] Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly[0] Breast Cancer Drugs May Fight Cervical Cancer, Too[0] No Gender Gap Found for Clot-Busting Drug
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |